Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
CureDuchenne link is a data hub comprised of integrated biospecimens, clinical data, and self- and/or caregiver-reported information from participants. Anyone over 4 weeks old who has been diagnosed with DMD or BMD or who is a carrier of DMD or BMD can join. Parents or legal guardians can sign up their child(ren).
Individuals can participate through the CureDuchenne Link⢠application (accessible via mobile device or web interface) and receive communications about research opportunities and community programs. Participation may be done using virtual methods, at a project site, and/or at community events nationwide.
All collected information will be stored in a secure, HIPAA-compliant data warehouse for approved researchers to use for studies relevant to DMD, BMD and other neuromuscular disorders. Combining health and outcomes data with biospecimens provides an impactful solution and novel resource for researchers, allowing for effective translational research.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Duchenne and Becker muscular dystrophy | Individuals with Duchenne muscular dystrophy and Becker muscular dystrophy | ||
| Carriers | Carriers of Duchenne muscular dystrophy and Becker muscular dystrophy |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Diagnosis | There is no intervention in this project. Participants will provide documentation to support their diagnosis of Duchenne muscular dystrophy, Becker muscular dystrophy, or a carrier of these mutations | Upon study entry |
| Genetic Mutation | Participants will be asked to provide genetic testing reports confirming their diagnosis, where available, which will be reviewed by a central genetic counselor. | Upon study entry or when genetic testing results are available |
| Measure | Description | Time Frame |
|---|---|---|
| Functional Status | Self reported data (questionnaire on ambulation and mobility) will be captured | Upon study entry and every 6-12 months thereafter for up to ten (10) years |
| North Star Ambulation Assessment (NSAA) Score |
Not provided
Inclusion Criteria:
Any of the following are true:
Parent/guardian (for minor participants) or participant gives informed consent and/or assent as required by local regulations.
Is age 4 weeks or older at the time of consent.
Exclusion Criteria:
Not provided
Not provided
Not provided
Individuals with or carriers of Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD).
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Erica Rudoff | Contact | 888-235-4655 | support@cureduchennelink.org |
| Name | Affiliation | Role |
|---|---|---|
| Debra Miller | CureDuchenne | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Arkansas Children's Hospital | Recruiting | Little Rock | Arkansas | 72202 | United States |
Not provided
| Label | URL |
|---|---|
| CureDuchenne Link Information Page | View source |
Not provided
After a thorough application process, data will be shared to qualified researchers.
Approved researchers will complete all required CDA/data transfer agreements with CureDuchenne. Once complete, they will be given access to a limited dataset with direct identifiers removed.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020388 | Muscular Dystrophy, Duchenne |
| ID | Term |
|---|---|
| D009136 | Muscular Dystrophies |
| D020966 | Muscular Disorders, Atrophic |
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood, Urine, Saliva, Muscle and Skin will be collected. Sample collection will be optional.
Clinically reported NSAA scores will be captured
| Upon study entry and every 6-12 months thereafter for up to ten (10) years |
| 6 Minute Walk Test (6MWT) Score | Clinically reported 6MWT scores will be captured | Upon study entry and every 6-12 months thereafter for up to ten (10) years |
| Corticosteroid Status | Self reported and clinically reported corticosteroid status (past and present) will be captured | Upon study entry and every 6-12 months thereafter for up to ten (10) years |
| Cardiac Status | Self reported and clinically reported cardiac status (past and present) will be captured | Upon study entry and every 6-12 months thereafter for up to ten (10) years |
| Respiratory Status | Self reported and clinically reported respiratory status (past and present) will be captured | Upon study entry and every 6-12 months thereafter for up to ten (10) years |
| CureDuchenne | Recruiting | Newport Beach | California | 92660 | United States |
|
| Children's Hospital of Orange County | Recruiting | Orange | California | 92868 | United States |
|
| Rare Disease Research | Recruiting | Atlanta | Georgia | 30329 | United States |
|
| University of Iowa | Recruiting | Iowa City | Iowa | 52242 | United States |
|
| Kansas University Clinical Research Center | Recruiting | Fairway | Kansas | 66205 | United States |
|
| Corewell Health | Recruiting | Grand Rapids | Michigan | 49503 | United States |
|
| Rare Disease Research Center | Recruiting | Hillsborough | North Carolina | 27278 | United States |
|
| Penn State Health | Recruiting | Hershey | Pennsylvania | 17033 | United States |
|
| Neurology Rare Disease Center | Recruiting | Denton | Texas | 76208 | United States |
|
| D009468 | Neuromuscular Diseases |
| D009422 | Nervous System Diseases |
| D040181 | Genetic Diseases, X-Linked |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |